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ABSTRACT:
23 Human telomerase functions in maintaining genome stability by adding telomeric repeats to the 24 termini of linear chromosomes. Past studies have revealed profound insights into telomerase 25 functions. However, low abundance of functional telomerase and difficulty in quantifying its 26 activity leave partially characterized its thermodynamic and kinetic properties. Using a newly 27 developed method to count individual extension products, we demonstrate that human 28 telomerase holoenzymes contain fast-and slow-acting catalytic sites. Surprisingly, both active 29 sites become inactive after two consecutive rounds of catalysis. The fast active sites turn off ~40-
30
fold quicker than the slow ones and exhibit higher affinity to substrates. In dimeric enzymes, the 31 two sites work in tandem with the faster site functioning before the slower one. In monomeric 32 enzymes, the active sites also perform single-run catalysis. Interestingly, the inactive enzymes control of telomerase activity is expected to play important roles in cell division and ageing.
38

INTRODUCTION
40
Telomeres refer to the terminal sequences of linear chromosomes in eukaryotic cells 1 
RESULTS
93
In single-turnover settings, human telomerase becomes inactive after two sequential runs of In order to analyze telomerase activity quantitatively, we took advantage of telomerase's ability 96 to stably bind telomeric repeats (TTAGGG) 3 (R3) at the GGG position, but quickly fall off when 97 it adds three nucleotides to the substrate and reaches the TTA position in vitro (Fig. 1A hTERT, ~10 kDa heavier than the endogenous one in SDS-PAGE, was indeed biotinylated.
121
Biotinylation provided an effective way to selectively enrich recombinant telomerase, and 122 allowed the separation of the recombinant hTERT from the endogenous hTERT as well as 
125
We used a two-step pull-down procedure in order to enrich selectively endogenous telomerase 126 holoenzymes (Fig. 1A) . Between the two steps, apyrase was introduced to remove dATP/dTTP 127 from the eluate of the first pulldown (Supplementary Fig. S4 ). An aliquot of the sample loaded to to hydrolyze dTTP and dATP in the Elution 1 before the eluate was mixed to fresh R3 beads
134
(Input 2 in Fig. 1B) . Surprisingly, although we expected to recover ~25% of the loaded When analyzed in a time-lapsed fashion, the tethered telomerase was stable for at least 4-5 hours 161 at room temperature ( Fig. 1C and Fig. 2A-B) , suitable for the kinetic analysis. After each run of 162 processive extension, longer than the half-turn addition of 3-nucleotides in Fig. 1A , the products
163
were separated from the enzymes and quantified (Fig. 1D) . During the second run (Ext 2 in Fig.   164 1D), the reaction products were 60-70% of those from the first run (Ext 1). During the third run
165
(Ext 3), the yield dropped to < 10% of those in the first run with the same amount of tethered 166 enzyme. As a control, the same enzyme preparation going through the same mechanical 167 manipulations for three rounds without seeing the telomeric TS primers (DNA substrates) in the 168 first two runs generated nearly the same amount of products (Ext 1* in Fig. 1D 
177
We tested all of these possibilities. First, partially purified telomerase using streptavidin-beads or 178 other methods were stable for a few days at 4 °C ( Fig. 2A and Supplementary Figs S5A-C) or 179 for 5-6 hours at room temperature ( Fig. 2B ) with the loss of activity limited to 5-15%. The 180 endogenous telomerase directly from cell lysates, which also shut off after two runs of 181 extensions, lost a bit more activity (35%) over a period of 5 hours ( Supplementary Fig. 1B ), but
182
it is much lower than the > 90% use-dependent loss. We thus preferentially used partially 183 purified enzymes for our studies.
185
Second, western blot of both endogenous and recombinant hTERT found that the tethered 186 enzymes after two rounds of extension reactions (Fig. 1D ) suffered from no obvious hTERT 187 degradation (Fig. 2C) . Third, RT-qPCR analysis of the hTR content found that the "Elution 2"
188 fraction in Fig. 1B had ~25% of the hTR in the Elution 1 as we expected, but ZERO activity in 189 even 100 x more materials (Fig 1B & supplementary Fig. S6 ). Fourth, using the recombinant contained the products from the first round of catalysis, it produced a similar amount of products
194
(the total product amount doubled as in Fig. 2D ). No product inhibition existed for telomerase. (Fig. 3D) period of 3 to 6 hours ( Fig. 2A) . The same was found to be true for telomerase enriched in 253 glycerol-gradient fractions of cell lysates (Fig. 3D) , the fractions eluted from single-step 254 pulldown (Fig 1B) , and the fractions of the biotinylated enzymes eluted from the monomeric 255 avidin beads (Fig. 3B) . 
276
The released products were quantified by ddTRAP and normalized against the total products at Compared to the two kinetic components of the endogenous telomerase, the telomerase from the 290 one-step single-turnover affinity purification using the R3-beads exhibited only the slow 291 component (Fig. 4B) . Because the single-turnover affinity purification would remove all 292 monomeric enzymes (fast or slow), the leftover enzymes must be dimeric (Fig 4B) , which has remained bound to the beads or were able to add 3-nt and elute out, were removed such that the 298 Elution 1 fraction (Fig. 4B) was dominated by the dimeric enzymes with slow-acting active sites
299
(E 1 ). The two kinetic components were different in time domain such that two exponential 300 components were needed to fit the data (Figs 4E-F Fig. 4E-F) , we estimated two kinetic
333
constants from these models, ~0.4 min -1 and 0.01 min -1 for the fast and the slow components, 334 respectively (Fig. 4H) . All Markov models fitted the time-lapse data reasonably well. The 335 sequential model with a delay worked slightly better than the others. We would like to test whether the dimers can act as in a sequential model. We used the tethered 347 recombinant telomerase holoenzymes, which were physically separated from each other by at 348 least 50 nm on the surfaces of streptavidin-coated beads so that on average, two neighboring 349 separate enzyme complexes were physically independent of each other (Fig 5A) added. However, our data showed the opposite. In the second round of reaction the tethered 371 enzymes with no fresh substrates ("-TS") exhibited a significant drop (~75% less) in extension 372 products, when compared to the control sample (Fig. 5B) (Figs 4C-4D ).
402
As depicted in Fig. 4G , a dimeric enzyme with two different active sites may have three different
403
states. The dimers in cell lysates thus belong to three subgroups ----E 0 , E 1 and E 2 . In the first 404 round of extension, the pristine enzymes (E 0 ) were converted to E 1 (Fig. 1A) , and a small supported by experimental data (Fig 5B) and can explain the kinetic property of the dimers (Fig.   409   4G ). Between the two monomeric forms, the slow sM 1 enzymes behaved the same as the E1 and 410 contributed partially to the products seen in Extension 2 (-TS) and the fast fM1 enzymes (36% in 411 the mixture) turned into inactive M 2 (Fig. 5B) . its time-constant, the fast-acting sites became completely inactive after ~10 minutes (Round 1).
420
The fixed amount of time in the three rounds within the regime of a sequential models predicted 421 that the total products from the three rounds would be similar for three groups. Group 1 (30 min 422 extension in round 1, Fig. 5C ) had the lowest activity in the first round, but greater activity in instead of single-turnover (Fig. 4G) .
431
A significant fraction (~44%) of functional enzymes in the cell lysates were dimeric E 0 . Our 432 analysis accounted for the existence of monomeric enzymes, which followed single-exponential 433 kinetics (Fig. 4G) . Combination of the sequential model for the dimeric holoenzymes with the 434 parallel model for two monomeric forms was thus able to fit all experimental data very well 435 (Figs 4 and supplementary Fig. S7 ). It is thus not necessary to biochemically purified the 436 telomerase monomers from the dimers for us to deduce the fundamental property of the enzyme.
437
A simple assumption of the fM 1 and sM 1 following the kinetics for fast-and slow-acting sites 438 was sufficient for reaching the biophysical understanding (Fig. 4H) . 
439
Intracellular telomerase-activating factors (iTAFs) turn on inactive telomerases
446
This led us to the question whether it is possible to turn on the inactive telomerase.
448
We first tested the cell lysates from a telomerase-negative cell line, BJ fibroblasts, and used 449 ddTRAP to quantify the fraction of enzymes that were reactivated (Fig. 6A) . The tethered 450 enzymes on the streptavidin-coated beads were made fully inactive after three rounds of 451 extension reactions (in E 2 or M 2 states in Fig. 6B ). Afterwards the beads with inactive enzymes 452 were mixed with the BJ cell lysates and the extension reaction mixture for 2 hours before the 453 extended products were counted using ddTRAP. To our surprise, the cell lysates from the 454 telomerase-negative BJ cells were able to reactivate a significant fraction of inactive enzymes (as 455 exemplified in Fig. 6B ). As a negative control, the BJ cell lysates had no activity (Fig. 6B) .
456
These results clearly demonstrated that the BJ cells contain intracellular telomerase-activating 457 factors (iTAFs) that can reactivate the inactive holoenzymes (E 2 and M 2 ). The same iTAF 458 activity was detected in other types of telomerase-negative proliferating cells, such as SAOS-2
459
and SKLU-1 (Fig. 6F) .
460
When partially purified telomerase holoenzymes were incubated with iTAFs, the time-lapse 462 experiments showed that the activation by iTAFs increased the amount of the fast-acting sites (E 0 463 or fM 1 ) by only a small fraction (~25%), but boosted the slow-acting active sites (E 1 or sM 1 ) 464 much more significantly (~480%) (Fig. 6C vs. 6D) . The control telomerase (Fig. 6C) . S7 ).
472
The iTAFs are proteineous components. We were able to separate iTAFs from the telomerase 473 fractions in a glycerol gradient. The iTAFs heated in a boiling temperature lost their activity in 474 reactivating the inactive enzymes (Fig. 6E) . DNAse treatment of iTAFs had almost no effect on 475 their activity (Fig. 6E) . When the cell lysates were fractionated and eluted in a Superdex 200 476 column, the iTAFs were found to be equivalent to an ~150 kDa globular protein (supplementary (Fig. 5B) .
491
More importantly, both types of active sites perform single-run catalysis (Fig. 7A) , and iTAFs
492
can turn the inactive enzymes (E 2 or M 2 ) into different active states (Fig. 7B) . Our results can be 493 incorporated into a kinetic model in Fig. 7A , where one active site goes through one round of 494 processive extension reaction and becomes inactive after it falls off the product (Figs 1A-B) .
495
The inactive site can be turned back on (step IV; recycle). The switching of the enzymes between The sequential action of the two sites in a dimeric telomerase (Fig. 7B) phase. This mechanism indicates a possible role of the iTAFs in regulating the S/G2 transition.
517
Single-run catalysis of human telomerase
518
When counting the extension products by ddTRAP with single digit accuracy, we could avoid 519 complications from the average length of extension products, the differences in catalysis rates,
520
and the possible delay between the moment the fast site in a dimer is turned off and the time 521 point when the slow site becomes accessible to a new substrate (Fig. 4G) . Using the substrate 522 pull-down to select only active enzymes in the single-turnover setting (Figs 1A-1B 
MATERIALS AND METHODS
610
Cells used for preparing active telomerases were either H1299 lung adenocarcinoma cells or RNA purification, reverse transcription to produce cDNA, and qPCR using proper primers 617 against hTR cDNAs.
619
Gel-based TRAP assay was performed as described before 63 . Digital droplet PCR (ddPCR)- beads. After complete wash to remove free R3, the R3-conjugated beads was used for single-
640
step pull-down of human telomerase holoenzymes as described before 32 . dATP/dTTP were used 641 to elute the bound enzymes from the beads. Apyrase treatment was introduced to remove the 642 nucleotides when two such pull-down steps were performed in tandem. fractions were tested and subjected to further kinetic analysis.
660
The on-line supplementary information contains more details for each step. 
